Jennifer Tousignant
General Counsel bij VIRIDIAN THERAPEUTICS, INC.
Profiel
Jennifer Tousignant is currently the Chief Legal Officer at Viridian Therapeutics, Inc. She previously worked as the Senior Vice President-Legal at Sana Biotechnology, Inc. and as a Member-Global Launch Teams at Genzyme Corp.
In addition, she served as the Head-Legal at Xilio Therapeutics, Inc. in 2020 and as the Chief Intellectual Property Counsel at Tesaro, Inc. from 2016 to 2019.
Ms. Tousignant completed her undergraduate studies at the University of Virginia and obtained a graduate degree from Suffolk University Law School.
Actieve functies van Jennifer Tousignant
| Bedrijven | Functie | Begin |
|---|---|---|
| VIRIDIAN THERAPEUTICS, INC. | General Counsel | 15-02-2024 |
Eerdere bekende functies van Jennifer Tousignant
| Bedrijven | Functie | Einde |
|---|---|---|
| XILIO THERAPEUTICS, INC. | General Counsel | 01-11-2020 |
| TESARO INC | General Counsel | 01-10-2019 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
| SANA BIOTECHNOLOGY, INC. | General Counsel | - |
Opleiding van Jennifer Tousignant
| University of Virginia | Undergraduate Degree |
| Suffolk University Law School | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| XILIO THERAPEUTICS, INC. | Health Technology |
| VIRIDIAN THERAPEUTICS, INC. | Health Technology |
| SANA BIOTECHNOLOGY, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Tesaro, Inc.
 Tesaro, Inc. Pharmaceuticals: MajorHealth Technology TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. The firm offers Niraparib products. The company was founded by Leon Oliver Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA. | Health Technology |
